Drospirenone Synthesis Using TEMPO Catalytic Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current processes for producing drospirenone face challenges due to the use of hazardous reagents like chromic anhydride and require complex reagent additions and analytical controls, making them unsuitable for industrial-scale, continuous production.
Innovation Solution
A process involving the reaction of 17α-(3-hydroxypropyl)-6β,7β;15β,16β-dimethylene-5β-androstane-3β,5,17β-triol with gaseous oxygen, catalytic amounts of 2,2,6,6-tetramethylpiperidine-1-oxyl radical, ferric salt, and sodium chloride in an acidic solvent at controlled temperatures, allowing for direct synthesis of drospirenone in a single step without the need for subsequent reagent additions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If chromic anhydride is used as oxidant in the preparation of drospirenone, then the oxidation reaction can proceed, but the process becomes hazardous and subject to legislative restrictions due to carcinogenic properties
Solution Approach 1:
The patent changes the chemical parameters by replacing chromic anhydride with calcium hypochlorite as the oxidant and introducing 2,2,6,6-tetramethylpiperidine-1-oxyl radical as a catalyst. This parameter substitution eliminates the carcinogenic hazard while maintaining oxidation capability, as calcium hypochlorite is non-carcinogenic and the radical catalyst enables efficient oxidation without requiring hazardous reagents.
Solution Approach 2:
The patent introduces 2,2,6,6-tetramethylpiperidine-1-oxyl radical as an intermediary catalyst that mediates the oxidation reaction. This catalyst enables the use of safer oxidants like calcium hypochlorite while maintaining high oxidation efficiency, thus resolving the contradiction between reaction capability and safety.
2Ease of manufacture
If potassium bromate with ruthenium salts is used as oxidant system, then the oxidation reaction can proceed, but the process becomes complex requiring complete elimination of metal catalysts from the product
Solution Approach 1:
The patent employs 2,2,6,6-tetramethylpiperidine-1-oxyl radical as a temporary catalyst that can be easily removed or decomposed. This short-living catalyst system avoids the need for complex metal removal processes, as the organic radical catalyst can be separated more simply compared to metal catalysts like ruthenium salts, reducing purification complexity.
Solution Approach 2:
The patent uses 2,2,6,6-tetramethylpiperidine-1-oxyl radical as an intermediary that facilitates the oxidation reaction without requiring metal catalysts. This intermediary approach eliminates the need for complex metal removal procedures while maintaining efficient oxidation, thus reducing overall process complexity.
3Manufacturing precision
If calcium hypochlorite is added in portions with analytical controls, then the oxidation can be controlled, but the process requires multiple reagent additions and analytical controls hindering continuous industrial production
Solution Approach 1:
The patent enables continuous production by using a catalytic system with 2,2,6,6-tetramethylpiperidine-1-oxyl radical and calcium hypochlorite that allows single-addition oxidation. The catalyst system maintains continuous oxidation activity without requiring repeated reagent additions or analytical controls, thus achieving both precision and continuous productivity suitable for industrial scales.
Solution Approach 2:
The catalytic system with 2,2,6,6-tetramethylpiperidine-1-oxyl radical enables the oxidation to proceed autonomously without requiring continuous monitoring or partial additions. The catalyst facilitates self-regulating oxidation that maintains precision while enabling continuous operation, eliminating the need for operator interventions during the reaction process.
4Productivity
If a simple oxidation process is used, then the process can be standardized for continuous production, but the yield and reaction control may be compromised
Solution Approach 1:
The patent optimizes parameters by using controlled temperatures (30-50°C), specific catalyst amounts (catalytic amounts of 2,2,6,6-tetramethylpiperidine-1-oxyl radical), and controlled oxidant addition. These parameter changes enable the simple oxidation process to achieve both continuous production capability and precise reaction control, as the optimized conditions ensure complete oxidation while maintaining process simplicity for standardization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method eliminates the use of hazardous reagents, minimizes operator interventions, and achieves consistent yields of drospirenone, facilitating standardized industrial production with yields ranging from 60 to 85%, while ensuring compliance with industry regulations.
Implementation Method 1
the reaction of the compound 17α-(3-hydroxypropyl)-6β,7β;15β,16β-dimethylene-5β-androstane-3β,5,17β-triol with gaseous oxygen in the presence of catalytic amounts of 2,2,6,6-tetramethylpiperidine-1-oxyl radical (or a derivative thereof), a ferric salt and sodium chloride
Data Source
AI summary
A process is described wherein, by employing 17a-(3-hydroxypropyl) -63,7β3;15β,16β-dimethylene-5β-androstane-3β,5,17β-triol (II) as starting product, in a single stage reaction there is obtained drospirenone, (I), whereby the reaction is achieved using gaseous oxygen as the stoichiometric oxidant in the presence of a catalytic system containing (i) TEMPO or a derivative thereof, (ii) a ferric salt (Fe3+) and (iii) NaCI. The product drospirenone is a known synthetic steroid with progestogenic, antimineralocorticoid and antiandrogenic action, that is useful for preparing pharmaceutical compositions with contraceptive action.